Posted: 23 July 2026 - Cambridge, United Kingdom
The position involves developing cellular and animal models to study alpha-synuclein aggregation related to Parkinson's disease. The successful candidate will collaborate with various national and international groups, utilizing techniques such as human iPSC cultures, immunohistochemistry, and cryo-EM. Applicants must have or be close to obtaining a PhD, with prior experience in relevant techniques being advantageous. The role is fixed-term until May 31, 2029, with a salary range depending on qualifications.